# Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT)

> **NCT07428213** · NA · NOT_YET_RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 40 (estimated)

## Conditions studied

- Meningioma

## Interventions

- **OTHER:** PET PSMA

## Key facts

- **NCT ID:** NCT07428213
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07428213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07428213, "Measurement of PSMA Expression in Vivo in Recurrent Meningiomas by PET Imaging: a Preliminary Study to a Therapeutic Trial Using Radioligand Therapy (RLT)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07428213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*